CD19 and systemic sclerosis: In their recently published study, Müller et al. included 15 patients with refractory rheumatic autoimmune disorders—8 with SLE, 3 with idiopathic inflammatory myopathies (IIMs), and 4 with SSc—who received autologous CD19 CAR-T cells after LDC [25].